123 related articles for article (PubMed ID: 6340760)
1. Cell-marker studies in CLL with monoclonal OKT antisera and lactic dehydrogenase isoenzyme analysis.
Sabbe L; Plum J; De Smedt M; Leroux G; Louwagie A; Criel A
Blut; 1983 May; 46(5):261-70. PubMed ID: 6340760
[TBL] [Abstract][Full Text] [Related]
2. Administration of prednisolone in vivo affects the ratio of OKT4/OKT8 and the LDH-isoenzyme pattern of human T lymphocytes.
ten Berge RJ; Sauerwein HP; Yong SL; Schellekens PT
Clin Immunol Immunopathol; 1984 Jan; 30(1):91-103. PubMed ID: 6607798
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody studies in B-cell chronic lymphocytic leukemia and allied disorders.
Aisenberg AC; Wilkes BM
Hematol Oncol; 1983; 1(1):13-9. PubMed ID: 6610619
[TBL] [Abstract][Full Text] [Related]
4. Disturbances in T-cell subpopulations in B-cell chronic lymphocytic leukaemia.
Johnstone AP; Height S; Millard RE
Biosci Rep; 1982 Aug; 2(8):535-42. PubMed ID: 6182930
[TBL] [Abstract][Full Text] [Related]
5. Lactic dehydrogenase in normal and leukemia lymphocyte subpopulations: evidence for the presence of abnormal T cells and B cells in chronic lymphocytic leukemia.
Rambotti P; Davis S
Blood; 1981 Feb; 57(2):324-7. PubMed ID: 6969615
[TBL] [Abstract][Full Text] [Related]
6. Imbalance of T cell subpopulations in patients with chronic lymphocytic leukaemia of the B cell type.
Herrmann F; Lochner A; Philippen H; Jauer B; Rühl H
Clin Exp Immunol; 1982 Jul; 49(1):157-62. PubMed ID: 6982129
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody-defined B-cell, T-cell and myelomonocytic antigens and other surface determinants on leukemic B cells of chronic lymphocytic leukemia.
Han T; Ozer H; Minowada J
Prog Clin Biol Res; 1983; 133():135-44. PubMed ID: 6604920
[TBL] [Abstract][Full Text] [Related]
9. Unusual T-cell phenotype in advanced B-chronic lymphocytic leukaemia.
Matutes E; Wechsler A; Gomez R; Cherchi M; Catovsky D
Br J Haematol; 1981 Dec; 49(4):635-42. PubMed ID: 6459116
[TBL] [Abstract][Full Text] [Related]
10. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
11. Discrepancy between phenotypic and functional features of natural killer T-lymphocytes in B-cell chronic lymphocytic leukaemia.
Foa R; Lauria F; Lusso P; Giubellino MC; Fierro MT; Ferrando ML; Raspadori D; Matera L
Br J Haematol; 1984 Nov; 58(3):509-16. PubMed ID: 6333890
[TBL] [Abstract][Full Text] [Related]
12. T cell subpopulations in CLL: methods of T cell enrichment artificially alter proportions of OKT4 and OKT8 positive cells.
Dickinson AM; George S; Proctor SJ
Clin Exp Immunol; 1983 Nov; 54(2):525-31. PubMed ID: 6606510
[TBL] [Abstract][Full Text] [Related]
13. Chronic lymphocytic leukemia: a monoclonal disease.
Solanki DL; McCurdy PR; MacDermott RP
Am J Hematol; 1982 Sep; 13(2):159-62. PubMed ID: 6982616
[TBL] [Abstract][Full Text] [Related]
14. Lactate dehydrogenase (LDH) isoenzymes and proliferative activity of lymphoid cells--an immunocytochemical study.
Pan L; Beverley PC; Isaacson PG
Clin Exp Immunol; 1991 Nov; 86(2):240-5. PubMed ID: 1934592
[TBL] [Abstract][Full Text] [Related]
15. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.
Caligaris-Cappio F; Gobbi M; Bofill M; Janossy G
J Exp Med; 1982 Feb; 155(2):623-8. PubMed ID: 6977012
[TBL] [Abstract][Full Text] [Related]
16. Comparison of different markers on blood lymphocytes of chronic lymphocytic leukemia.
Götze D; Fiebig H; Mansfeld HW; Mey U; Schön E; Uhle R; Ansorge S
Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(2):233-40. PubMed ID: 2410330
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody Ki-67 identifies B and T cells in cycle in chronic lymphocytic leukemia: correlation with disease activity.
Cordone I; Matutes E; Catovsky D
Leukemia; 1992 Sep; 6(9):902-6. PubMed ID: 1387694
[TBL] [Abstract][Full Text] [Related]
18. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes in B-cell chronic lymphocytic leukemia: characterization by monoclonal antibodies and correlation with Fc receptors.
Semenzato G; Pezzutto A; Foa R; Lauria F; Raimondi R
Clin Immunol Immunopathol; 1983 Feb; 26(2):155-61. PubMed ID: 6223743
[TBL] [Abstract][Full Text] [Related]
20. Subtyping of chronic lymphocytic leukemia of T-type by dipeptidylaminopeptidase IV (DAP IV), monoclonal antibodies, and Fc-receptors.
Feller AC; Parwaresch MR; Lennert K
Cancer; 1983 Nov; 52(9):1609-12. PubMed ID: 6137274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
